Akebia Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Akebia Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2024.
  • Akebia Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $1.4M, unchanged year-over-year.
  • Akebia Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $5.6M, a 11.1% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $5.9M, a 18.1% decline from 2022.
  • Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.2M, a 1.41% increase from 2021.
  • Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $7.1M, a 1.43% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.6M $1.4M $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.6M $1.4M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.6M $1.4M -$300K -17.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.9M $1.4M -$400K -22.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $6.3M $1.4M -$400K -22.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $6.7M $1.4M -$400K -22.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $7.1M $1.7M -$100K -5.56% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $7.2M $1.8M +$100K +5.88% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $7.1M $1.8M $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $7.1M $1.8M $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-28
Q1 2022 $7.1M $1.8M $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $7.1M $1.7M $0 0% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 $7.1M $1.8M $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $7.1M $1.8M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7.1M $1.8M +$100K +5.88% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $7M $1.7M -$100K -5.56% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
Q3 2020 $7.1M $1.8M +$100K +5.88% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $7M $1.8M +$100K +5.88% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $6.9M $1.7M $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $6.9M $1.8M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.7M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.7M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.